Chemoinformaics analysis of 4-O-methylsappanol
| Molecular Weight | 318.325 | nRot | 3 |
| Heavy Atom Molecular Weight | 300.181 | nRig | 17 |
| Exact Molecular Weight | 318.11 | nRing | 3 |
| Solubility: LogS | -3.22 | nHRing | 1 |
| Solubility: LogP | 1.921 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 45.2043 |
| nHD | 4 | BPOL | 21.5297 |
| QED | 0.645 |
| Synth | 3.572 |
| Natural Product Likeliness | 2.045 |
| NR-PPAR-gamma | 0.109 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.725 |
| HIA | 0.118 |
| CACO-2 | -4.822 |
| MDCK | 0.00000889 |
| BBB | 0.028 |
| PPB | 0.945574 |
| VDSS | 0.616 |
| FU | 0.0673661 |
| CYP1A2-inh | 0.303 |
| CYP1A2-sub | 0.56 |
| CYP2c19-inh | 0.067 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.289 |
| CYP2c9-sub | 0.808 |
| CYP2d6-inh | 0.438 |
| CYP2d6-sub | 0.727 |
| CYP3a4-inh | 0.587 |
| CYP3a4-sub | 0.327 |
| CL | 15.408 |
| T12 | 0.854 |
| hERG | 0.036 |
| Ames | 0.756 |
| ROA | 0.287 |
| SkinSen | 0.951 |
| Carcinogencity | 0.271 |
| EI | 0.907 |
| Respiratory | 0.429 |
| NR-Aromatase | 0.845 |
| Antiviral | Yes |
| Prediction | 0.776552 |